MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways.
Laé, Marick
MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways. [electronic resource] - Oncotarget Dec 2016 - 84428-84438 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.12991 doi
Adolescent
Adult
Aged
Breast Neoplasms--genetics
Child
Chromosome Aberrations
Disease-Free Survival
Female
Gene Expression Regulation, Neoplastic
Genetic Heterogeneity
Humans
Mediator Complex--genetics
Middle Aged
Mutation
Neoplasm Recurrence, Local
Phyllodes Tumor--genetics
Signal Transduction--genetics
Young Adult
MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways. [electronic resource] - Oncotarget Dec 2016 - 84428-84438 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.12991 doi
Adolescent
Adult
Aged
Breast Neoplasms--genetics
Child
Chromosome Aberrations
Disease-Free Survival
Female
Gene Expression Regulation, Neoplastic
Genetic Heterogeneity
Humans
Mediator Complex--genetics
Middle Aged
Mutation
Neoplasm Recurrence, Local
Phyllodes Tumor--genetics
Signal Transduction--genetics
Young Adult